Pro Medicus Limited (PME) Share Forecast & Price Target

Compare

156 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

PME Analyst Ratings

Hold

2 Buy

5 Hold

1 Sell

Based on 8 analysts giving stock ratings to

Pro

Medicus Limited

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

PME Stock 12 Month Forecast

Average Price Target

AU$318.36

▼(-2.93%Downside)

Based on 8 Wall Street analysts offering 12 month price targets for Pro Medicus Limited in the last 3 months. The average price target is AU$318.36 with a high forecast of AU$351.83 and a low forecast of AU$281.46. The average price target represents a -2.93% change from the last price of AU$327.98.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"107":"AU$107","352":"AU$352","168.25":"AU$168.3","229.5":"AU$229.5","290.75":"AU$290.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":351.82825808025,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$351.83</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":318.364347714,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$318.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":281.4626064642,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$281.46</span>\n  </div></div>","useHTML":true}}],"tickPositions":[107,168.25,229.5,290.75,352],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,281.68,287.0760198523269,292.47203970465387,297.86805955698077,303.2640794093077,308.6600992616346,314.05611911396153,319.4521389662885,324.8481588186154,330.24417867094235,335.64019852326925,341.03621837559615,346.4322382279231,{"y":351.82825808025,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,281.68,284.5018729010769,287.32374580215384,290.14561870323075,292.9674916043077,295.78936450538464,298.61123740646156,301.43311030753847,304.2549832086154,307.0768561096923,309.8987290107693,312.7206019118462,315.5424748129231,{"y":318.364347714,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,281.68,281.6632774203231,281.64655484064616,281.62983226096924,281.6131096812923,281.5963871016154,281.57966452193847,281.56294194226155,281.5462193625846,281.5294967829077,281.5127742032308,281.49605162355385,281.47932904387693,{"y":281.4626064642,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":108.992,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":119.836,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":143.979,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":150.474,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":180.444,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":195.62,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":248.602,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":249.891,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":278.145,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":253.25,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":199.22,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":281.87,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":281.68,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetAU$351.83

Average Price TargetAU$318.36

Lowest Price TargetAU$281.46

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

AU$358

Buy

9.15%

Upside

Reiterated

07/08/25

Pro Medicus Limited's strong financial performance and positive earnings call are the most significant factors driving its stock score. While technical indicators show bullish momentum, overvaluation concerns due to a high P/E ratio and low dividend yield slightly offset the strength. Overall, the company is well-positioned for growth, with positive market sentiment and significant contract wins.

Shane StoreyWilsons

Wilsons

AU$325

Hold

-0.91%

Downside

Reiterated

07/07/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Pro Medicus Limited (Other OTC: PMCUF) and Siemens Healthineers AG (Other OTC: SEMHF)

John HesterBell Potter

Bell Potter

AU$320

Hold

-2.43%

Downside

Downgraded

07/04/25

Bell Potter downgrades Pro Medicus Limited (PMCUF) to a Hold

Sinclair CurrieMA Financial Group

MA Financial Group

AU$323.69

Hold

-1.31%

Downside

Reiterated

07/04/25

MA Financial Group Remains a Hold on Pro Medicus Limited (PMCUF)

Iain WilkieMorgans

Morgans

AU$250→AU$280

Sell

-14.63%

Downside

Reiterated

07/04/25

Morgans Keeps Their Sell Rating on Pro Medicus Limited (PMCUF)

Unknown AnalystOrd Minnett

Not Ranked

Ord Minnett

AU$305

Hold

-7.01%

Downside

Reiterated

07/04/25

Ord Minnett Reaffirms Their Hold Rating on Pro Medicus Limited (PMCUF)

Garry SherriffRBC Capital

RBC Capital

AU$350

Hold

6.71%

Upside

Reiterated

07/03/25

Pro Medicus Limited (PMCUF) Gets a Hold from RBC Capital

Chris BoulusMorgan Stanley

Morgan Stanley

AU$310→AU$320

Buy

-2.43%

Downside

Reiterated

07/03/25

Analysts' Top Healthcare Picks: Pro Medicus Limited (PMCUF), Demant (WILLF)

Annabel LiGoldman Sachs

Goldman Sachs

AU$309→AU$310

Buy

-5.48%

Downside

Reiterated

06/27/25

Pro Medicus Limited (PMCUF) Receives a Buy from Goldman Sachs

Christine TrinhMacquarie

Macquarie

AU$258.5→AU$257.4

Hold

-21.52%

Downside

Reiterated

03/27/25

David LowJ.P. Morgan

J.P. Morgan

AU$130→AU$282

Hold

-14.02%

Downside

Reiterated

02/14/25

Pro Medicus (PME:AU) (PMCUF) PT Raised to AUD282 at JPMorganJPMorgan analyst David Low raised the price target on Pro Medicus (PME:AU) (OTC: PMCUF) to AUD282.00 (from AUD130.00) while maintaining a Neutral rating.

Andrew PaineCLSA

CLSA

AU$280→AU$308

Buy

-6.09%

Downside

Reiterated

02/14/25

Pro Medicus Ltd. (PME:AU) (PMCUF) PT Raised to AUD308 at CLSACLSA analyst Andrew Paine raised the price target on Pro Medicus Ltd. (PME:AU) (OTC: PMCUF) to AUD308.00 (from AUD280.00) while maintaining a Outperform (2) rating.

Mathieu ChevrierCiti

Citi

AU$150→AU$165

Sell

-49.69%

Downside

Reiterated

02/13/25

Pro Medicus Limited (PMCUF) Receives a Sell from Citi

Wei SimJefferies

Jefferies

AU$250

Hold

-23.78%

Downside

Reiterated

01/15/25

Jefferies Sticks to Their Hold Rating for Pro Medicus Limited (PMCUF)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

AU$358

Buy

9.15%

Upside

Reiterated

07/08/25

Shane StoreyWilsons

Wilsons

AU$325

Hold

-0.91%

Downside

Reiterated

07/07/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Pro Medicus Limited (Other OTC: PMCUF) and Siemens Healthineers AG (Other OTC: SEMHF)

John HesterBell Potter

Bell Potter

AU$320

Hold

-2.43%

Downside

Downgraded

07/04/25

Bell Potter downgrades Pro Medicus Limited (PMCUF) to a Hold

Sinclair CurrieMA Financial Group

MA Financial Group

AU$323.69

Hold

-1.31%

Downside

Reiterated

07/04/25

MA Financial Group Remains a Hold on Pro Medicus Limited (PMCUF)

Iain WilkieMorgans

Morgans

AU$250→AU$280

Sell

-14.63%

Downside

Reiterated

07/04/25

Morgans Keeps Their Sell Rating on Pro Medicus Limited (PMCUF)

Unknown AnalystOrd Minnett

Not Ranked

Ord Minnett

AU$305

Hold

-7.01%

Downside

Reiterated

07/04/25

Ord Minnett Reaffirms Their Hold Rating on Pro Medicus Limited (PMCUF)

Garry SherriffRBC Capital

RBC Capital

AU$350

Hold

6.71%

Upside

Reiterated

07/03/25

Pro Medicus Limited (PMCUF) Gets a Hold from RBC Capital

Chris BoulusMorgan Stanley

Morgan Stanley

AU$310→AU$320

Buy

-2.43%

Downside

Reiterated

07/03/25

Analysts' Top Healthcare Picks: Pro Medicus Limited (PMCUF), Demant (WILLF)

Annabel LiGoldman Sachs

Goldman Sachs

AU$309→AU$310

Buy

-5.48%

Downside

Reiterated

06/27/25

Pro Medicus Limited (PMCUF) Receives a Buy from Goldman Sachs

Christine TrinhMacquarie

Macquarie

AU$258.5→AU$257.4

Hold

-21.52%

Downside

Reiterated

03/27/25

David LowJ.P. Morgan

J.P. Morgan

AU$130→AU$282

Hold

-14.02%

Downside

Reiterated

02/14/25

Andrew PaineCLSA

CLSA

AU$280→AU$308

Buy

-6.09%

Downside

Reiterated

02/14/25

Mathieu ChevrierCiti

Citi

AU$150→AU$165

Sell

-49.69%

Downside

Reiterated

02/13/25

Pro Medicus Limited (PMCUF) Receives a Sell from Citi

Wei SimJefferies

Jefferies

AU$250

Hold

-23.78%

Downside

Reiterated

01/15/25

Jefferies Sticks to Their Hold Rating for Pro Medicus Limited (PMCUF)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Pro Medicus Limited

1 Month

xxx

Success Rate

8/9 ratings generated profit

Average Return

+9.17%

reiterated a xxx

rating 25 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 88.89% of your transactions generating a profit, with an average return of +9.17% per trade.

3 Months

xxx

Success Rate

7/9 ratings generated profit

Average Return

+19.80%

reiterated a xxx

rating 25 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +19.80% per trade.

1 Year

Annabel LiGoldman Sachs

Success Rate

9/9 ratings generated profit

Average Return

+71.83%

reiterated a buy rating 25 days ago

Copying Annabel Li's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +71.83% per trade.

2 Years

xxx

Success Rate

9/9 ratings generated profit

Average Return

+91.07%

reiterated a xxx

rating 25 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +91.07% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PME Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, PME has received 5 Buy Ratings, 6 Hold Ratings, and 2 Sell Ratings. PME average Analyst price target in the past 3 months is 318.36.

Each month's total comprises the sum of three months' worth of ratings.

PME Financial Forecast

PME Earnings Forecast

Next quarter’s earnings estimate for PME is AU$0.58 with a range of AU$0.56 to AU$0.60. The previous quarter’s EPS was AU$0.49. PME beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 45.65% of the time in the same period. In the last calendar year PME has Preformed in-line its overall industry.

PME Sales Forecast

Next quarter’s sales forecast for PME is AU$115.03M with a range of AU$109.96M to AU$120.30M. The previous quarter’s sales results were AU$97.19M. PME beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 51.30% of the time in the same period. In the last calendar year PME has Preformed in-line its overall industry.

PME Stock Forecast FAQ

What is AU:PME’s average 12-month price target, according to analysts?

Based on analyst ratings, Pro Medicus Limited’s 12-month average price target is 318.36.

What is AU:PME’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for AU:PME, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Pro Medicus Limited a Buy, Sell or Hold?

Pro Medicus Limited has a consensus rating of Hold, which is based on 2 buy ratings, 5 hold ratings and 1 sell ratings.

What is Pro Medicus Limited’s share price target?

The average share price target for Pro Medicus Limited is 318.36. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$351.83 ,and the lowest forecast is AU$281.46. The average share price target represents -2.93% Decrease from the current price of AU$327.98.

What do analysts say about Pro Medicus Limited?

Pro Medicus Limited’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of Pro Medicus Limited?

To buy shares of AU:PME, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Pro Medicus Limited (PME) Share Forecast & Price Target

PME Analyst Ratings

PME Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Pro Medicus Limited

PME Analyst Recommendation Trends

PME Financial Forecast

PME Earnings Forecast

PME Sales Forecast

PME Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts